Status:
COMPLETED
Effects of Peanuts on Immunity and Cardiometabolic Risk Factors
Lead Sponsor:
Loma Linda University
Collaborating Sponsors:
California Walnut Commission
Conditions:
Immune Response
Cardiometabolic Risk Factors
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The aim of the proposed study is two-fold: to determine whether the intake of peanuts (a) enhances immune function and (b) produces a desirable impact on selected cardiometabolic biomarkers and risk f...
Detailed Description
The aim of the proposed study is two-fold: to determine whether the intake of peanuts (a) enhances immune function and (b) produces a desirable impact on selected cardiometabolic biomarkers and risk f...
Eligibility Criteria
Inclusion
- adults between the ages of 18-70 years
Exclusion
- known intolerance or allergy to peanuts
- bad dentures unable to chew peanuts
- regular intake of peanuts and/or other nuts (\>3 ounces/week)
- use of immune-boosting supplements
- exposure to antibiotics and corticoids immediately prior to the study
- use of other medications or supplements that can interfere with the immune functions
- Individuals that received any vaccination (i.e flu or Covid 19) 6 months prior to the start of the study
Key Trial Info
Start Date :
January 31 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 26 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06159556
Start Date
January 31 2024
End Date
September 26 2024
Last Update
October 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Loma Linda University School of Public Health
Loma Linda, California, United States, 92350